Abstract
Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Drug Delivery Letters
Title: Delivery Systems for Applications in siRNA Technology
Volume: 1 Issue: 2
Author(s): Kathleen L. Hefferon
Affiliation:
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Abstract: Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Export Options
About this article
Cite this article as:
L. Hefferon Kathleen, Delivery Systems for Applications in siRNA Technology, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020118
DOI https://dx.doi.org/10.2174/2210304x11101020118 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subject index to volume 1
Current HIV Research Vaccine Ingredients: Components that Influence Vaccine Efficacy
Mini-Reviews in Medicinal Chemistry NS3 Helicases as Drug Targets
Current Chemical Biology Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design Genome Diversity of Emerging Paramyxoviruses
Current Genomics Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Inflammation & Allergy - Drug Targets (Discontinued) The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Current Neuropharmacology Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review
Coronaviruses Quantitative and Mechanistic Studies of Aβ Immunotherapy
CNS & Neurological Disorders - Drug Targets Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
CNS & Neurological Disorders - Drug Targets The Contribution of γδ T Cells to the Pathogenesis of EAE and MS
Current Molecular Medicine Neuroprotective Therapy for HIV Dementia
Current HIV Research Drug Targets from Genetics: Alpha-Synuclein
CNS & Neurological Disorders - Drug Targets Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Interleukin-18, From Neuroinflammation to Alzheimers Disease
Current Pharmaceutical Design An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets The Role of Immune System in Schizophrenia
Current Immunology Reviews (Discontinued) Novel Applications of Nanotechnology in Controlling HIV and HSV Infections
Current Drug Research Reviews Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling
Current Drug Targets